Infectious Diseases Society of America 2024 guidance on the treatment of antimicrobial-resistant gram-negative infections

PD Tamma, EL Heil, JA Justo… - Clinical infectious …, 2024 - academic.oup.com
Abstract Background The Infectious Diseases Society of America (IDSA) is committed to
providing up-to-date guidance on the treatment of antimicrobial-resistant (AMR) infections …

Infectious Diseases Society of America guidance on the treatment of AmpC β-lactamase–producing Enterobacterales, carbapenem-resistant Acinetobacter baumannii …

PD Tamma, SL Aitken, RA Bonomo… - Clinical infectious …, 2022 - academic.oup.com
Abstract The Infectious Diseases Society of America (IDSA) is committed to providing up-to-
date guidance on the treatment of antimicrobial-resistant infections. A previous guidance …

Advances in the microbiology of Stenotrophomonas maltophilia

JS Brooke - Clinical microbiology reviews, 2021 - Am Soc Microbiol
Stenotrophomonas maltophilia is an opportunistic pathogen of significant concern to
susceptible patient populations. This pathogen can cause nosocomial and community …

Efficacy of ceftazidime-avibactam plus aztreonam in patients with bloodstream infections caused by metallo-β-lactamase–producing Enterobacterales

M Falcone, GL Daikos, G Tiseo… - Clinical Infectious …, 2021 - academic.oup.com
Background In vitro data support the use of combination of aztreonam (ATM) with
ceftazidime-avibactam (CAZ-AVI), but clinical studies are lacking. The aim of our study was …

The revival of aztreonam in combination with avibactam against metallo-β-lactamase-producing Gram-negatives: a systematic review of in vitro studies and clinical …

C Mauri, AE Maraolo, S Di Bella, F Luzzaro, L Principe - Antibiotics, 2021 - mdpi.com
Infections caused by metallo-β-lactamase (MBL)-producing Enterobacterales and
Pseudomonas are increasingly reported worldwide and are usually associated with high …

Trends, epidemiology, and management of multi-drug resistant gram-negative bacterial infections in the hospitalized setting

S Morris, E Cerceo - Antibiotics, 2020 - mdpi.com
The increasing prevalence of antibiotic resistance is a threat to human health, particularly
within vulnerable populations in the hospital and acute care settings. This leads to …

Treatment of urinary tract infections in the era of antimicrobial resistance and new antimicrobial agents

MS Bader, M Loeb, D Leto, AA Brooks - Postgraduate medicine, 2020 - Taylor & Francis
Urinary tract infections (UTIs) caused by antibiotic-resistant Gram-negative bacteria are a
growing concern due to limited treatment options. Knowledge of the common uropathogens …

Pandrug-resistant Gram-negative bacteria: a systematic review of current epidemiology, prognosis and treatment options

S Karakonstantis, EI Kritsotakis… - Journal of Antimicrobial …, 2020 - academic.oup.com
Background The literature on the epidemiology, mortality and treatment of pandrug-resistant
(PDR) Gram-negative bacteria (GNB) is scarce, scattered and controversial. Objectives To …

Treatment options for K. pneumoniae, P. aeruginosa and A. baumannii co-resistant to carbapenems, aminoglycosides, polymyxins and tigecycline: an approach …

S Karakonstantis, EI Kritsotakis, A Gikas - Infection, 2020 - Springer
The management of carbapenem-resistant infections is often based on polymyxins,
tigecycline, aminoglycosides and their combinations. However, in a recent systematic …

Cefiderocol, a siderophore cephalosporin, as a treatment option for infections caused by carbapenem-resistant Enterobacterales

KS Kaye, T Naas, JM Pogue, GM Rossolini - Infectious Diseases and …, 2023 - Springer
Carbapenem-resistant Enterobacterales (CRE) remain a significant public health threat,
and, despite recent approvals, new antibiotics are needed. Severe infections caused by …